Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Epidermal growth factor receptor peptide vaccination induces cross-reactive immunity to human EGFR, HER2, and HER3.

Doyle HA, Koski RA, Bonafé N, Bruck RA, Tagliatela SM, Gee RJ, Mamula MJ.

Cancer Immunol Immunother. 2018 Oct;67(10):1559-1569. doi: 10.1007/s00262-018-2218-9. Epub 2018 Jul 28.

PMID:
30056598
2.

Structural studies of human glioma pathogenesis-related protein 1.

Asojo OA, Koski RA, Bonafé N.

Acta Crystallogr D Biol Crystallogr. 2011 Oct;67(Pt 10):847-55. doi: 10.1107/S0907444911028198. Epub 2011 Sep 8.

3.

Expression, purification, crystallization and preliminary X-ray analysis of a truncated soluble domain of human glioma pathogenesis-related protein 1.

Bonafé N, Zhan B, Bottazzi ME, Perez OA, Koski RA, Asojo OA.

Acta Crystallogr Sect F Struct Biol Cryst Commun. 2010 Nov 1;66(Pt 11):1487-9. doi: 10.1107/S1744309110035669. Epub 2010 Oct 28.

4.

TLR9-targeted biodegradable nanoparticles as immunization vectors protect against West Nile encephalitis.

Demento SL, Bonafé N, Cui W, Kaech SM, Caplan MJ, Fikrig E, Ledizet M, Fahmy TM.

J Immunol. 2010 Sep 1;185(5):2989-97. doi: 10.4049/jimmunol.1000768. Epub 2010 Jul 26.

5.

Fusion loop peptide of the West Nile virus envelope protein is essential for pathogenesis and is recognized by a therapeutic cross-reactive human monoclonal antibody.

Sultana H, Foellmer HG, Neelakanta G, Oliphant T, Engle M, Ledizet M, Krishnan MN, Bonafé N, Anthony KG, Marasco WA, Kaplan P, Montgomery RR, Diamond MS, Koski RA, Fikrig E.

J Immunol. 2009 Jul 1;183(1):650-60. doi: 10.4049/jimmunol.0900093. Epub 2009 Jun 17.

6.

A recombinant West Nile virus envelope protein vaccine candidate produced in Spodoptera frugiperda expresSF+ cells.

Bonafé N, Rininger JA, Chubet RG, Foellmer HG, Fader S, Anderson JF, Bushmich SL, Anthony K, Ledizet M, Fikrig E, Koski RA, Kaplan P.

Vaccine. 2009 Jan 7;27(2):213-22. doi: 10.1016/j.vaccine.2008.10.046. Epub 2008 Nov 7.

7.

The multifunctional protein glyceraldehyde-3-phosphate dehydrogenase is both regulated and controls colony-stimulating factor-1 messenger RNA stability in ovarian cancer.

Zhou Y, Yi X, Stoffer JB, Bonafe N, Gilmore-Hebert M, McAlpine J, Chambers SK.

Mol Cancer Res. 2008 Aug;6(8):1375-84. doi: 10.1158/1541-7786.MCR-07-2170.

8.

Antibodies targeting linear determinants of the envelope protein protect mice against West Nile virus.

Ledizet M, Kar K, Foellmer HG, Bonafé N, Anthony KG, Gould LH, Bushmich SL, Fikrig E, Koski RA.

J Infect Dis. 2007 Dec 15;196(12):1741-8. doi: 10.1086/523654.

PMID:
18190253
9.

West Nile virus envelope protein inhibits dsRNA-induced innate immune responses.

Arjona A, Ledizet M, Anthony K, Bonafé N, Modis Y, Town T, Fikrig E.

J Immunol. 2007 Dec 15;179(12):8403-9.

10.

Correlation of tumor phenotype with c-fms proto-oncogene expression in an in vivo intraperitoneal model for experimental human breast cancer metastasis.

Toy EP, Bonafé N, Savlu A, Zeiss C, Zheng W, Flick M, Chambers SK.

Clin Exp Metastasis. 2005;22(1):1-9.

PMID:
16132573
11.

Drosophila myosin V is required for larval development and spermatid individualization.

Mermall V, Bonafé N, Jones L, Sellers JR, Cooley L, Mooseker MS.

Dev Biol. 2005 Oct 1;286(1):238-55.

13.

SGK1, a potential regulator of c-fms related breast cancer aggressiveness.

Tangir J, Bonafé N, Gilmore-Hebert M, Henegariu O, Chambers SK.

Clin Exp Metastasis. 2004;21(6):477-83.

PMID:
15679045
14.

Molecular characterization of myosin V from Drosophila melanogaster.

Bonafé N, Sellers JR.

J Muscle Res Cell Motil. 1998 Feb;19(2):129-41. Erratum in: J Muscle Res Cell Motil 1999 Feb;20(2):239.

PMID:
9536440
15.
16.
17.

Photochemical cross-linking of the skeletal myosin head heavy chain to actin subdomain-1 at Arg95 and Arg28.

Bonafé N, Chaussepied P, Capony JP, Derancourt J, Kassab R.

Eur J Biochem. 1993 May 1;213(3):1243-54.

Supplemental Content

Loading ...
Support Center